Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment?

Publisher： Karger

E-ISSN： 1662-8063|19|3|144-152

ISSN： 1662-4246

Source： Public Health Genomics, Vol.19, Iss.3, 2016-06, pp. : 144-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Assessment of Two ‘Low-Tech’ Genetic Health Care Procedures Performed by Prenatal Care Providers in Washington State: Implications for Future Policy Development Activities

By  

Public Health Genomics, Vol. 2, Iss. 2-3, 2000-03 ,pp. : 61-68

Karger

Access to resources Recommend Favorite

The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics

By  

Public Health Genomics, Vol. 14, Iss. 1, 2010-10 ,pp. : 43-52

Karger

Access to resources Recommend Favorite

Managing Partnerships and Impact on Decision-Making: The Example of Health Technology Assessment in Genetics

By  

Public Health Genomics, Vol. 9, Iss. 1, 2006-02 ,pp. : 27-33

Karger

Access to resources Recommend Favorite